methylprednisolone hemisuccinate and Berger Disease

methylprednisolone hemisuccinate has been researched along with Berger Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hennigar, R; Lohavichan, V; Tumlin, JA	1
Hennigar, RA; Tumlin, JA	1

Trials

1 trial(s) available for methylprednisolone hemisuccinate and Berger Disease

Article	Year
Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Male; Methylprednisolone Hemisuccinate; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pulse Therapy, Drug; Time Factors	2003

Article

Year

Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:7

Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Male; Methylprednisolone Hemisuccinate; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pulse Therapy, Drug; Time Factors

2003

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Berger Disease

Article	Year
Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. Seminars in nephrology, 2004, Volume: 24, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone Hemisuccinate; Prednisone; Prospective Studies; Proteinuria; Pulse Therapy, Drug; Treatment Outcome	2004

Article

Year

Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.

Seminars in nephrology, 2004, Volume: 24, Issue:3

Topics: Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone Hemisuccinate; Prednisone; Prospective Studies; Proteinuria; Pulse Therapy, Drug; Treatment Outcome

2004